Guru Ownership Trend
Guru Analysis for Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $136.39 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $19.17 M net outflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 61.2%. Conversely, Joel Greenblatt reduced exposure by 49.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Travere Therapeutics, Inc. (TVTX)
Major holders include Renaissance Technologies (RenTech) ($58.43 M), Cliff Asness ($9.07 M), Ken Fisher ($1.01 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.37 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $19.17 M, with 1 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 2 fully exited TVTX. The total reported sell value was $19.23 M.
Yes, 0 managers opened new positions in TVTX, and 1 increased their existing holdings. The total reported buy value was $54,577.17.